Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations.
J Clin Oncol. 2021 Jun 10;39(17):1856-1864. doi: 10.1200/JCO.20.02903. Epub 2021 Mar 22.
J Clin Oncol. 2021.
PMID: 33750196
Free PMC article.
Clinical Trial.